Participation of nitric oxide in different models of experimental hypertension
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
19154086
DOI
10.33549/physiolres.931581
PII: 1581
Knihovny.cz E-resources
- MeSH
- Antihypertensive Agents pharmacology MeSH
- Antioxidants pharmacology MeSH
- Endothelium, Vascular drug effects metabolism physiopathology MeSH
- Nitric Oxide Donors pharmacology MeSH
- Hypertension drug therapy etiology metabolism physiopathology MeSH
- Hypertriglyceridemia complications genetics metabolism MeSH
- Blood Pressure MeSH
- Rats MeSH
- Sodium Chloride, Dietary MeSH
- Disease Models, Animal MeSH
- NG-Nitroarginine Methyl Ester MeSH
- Nitric Oxide deficiency metabolism MeSH
- Oxidative Stress MeSH
- Rats, Inbred SHR MeSH
- Rats, Wistar MeSH
- Stress, Psychological complications metabolism MeSH
- Sympathetic Nervous System physiopathology MeSH
- Nitric Oxide Synthase antagonists & inhibitors metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Antihypertensive Agents MeSH
- Antioxidants MeSH
- Nitric Oxide Donors MeSH
- Sodium Chloride, Dietary MeSH
- NG-Nitroarginine Methyl Ester MeSH
- Nitric Oxide MeSH
- Nitric Oxide Synthase MeSH
This review concerns the role of nitric oxide (NO) in the pathogenesis of different models of experimental hypertension (NO-deficient, genetic, salt-dependent), which are characterized by a wide range of etiology. Although the contribution of NO may vary between different models of hypertension, a unifying characteristic of these models is the presence of oxidative stress that participates in the maintenance of elevated arterial pressure and seems to be a common denominator underlying endothelial dysfunction in various forms of experimental hypertension. Besides the imbalance between the endothelial production of vasorelaxing and vasoconstricting compounds as well as the relative insufficiency of vasodilator systems to compensate augmented vasoconstrictor systems, there were found numerous structural and functional abnormalities in blood vessels and heart of hypertensive animals. The administration of antihypertensive drugs, antioxidants and NO donors is capable to attenuate blood pressure elevation and to improve morphological and functional changes of cardiovascular system in some but not all hypertensive models. The failure to correct spontaneous hypertension by NO donor administration reflects the fact that sympathetic overactivity plays a key role in this form of hypertension, while NO production in spontaneously hypertensive rats might be enhanced to compensate increased blood pressure. A special attention should be paid to the modulation of sympathetic nervous activity in central and peripheral nervous system. These results extend our knowledge on the control of the balance between NO and reactive oxygen species production and are likely to be a basis for the development of new approaches to the therapy of diseases associated with NO deficiency.
References provided by Crossref.org